Frazier Life Sciences Management, L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,440,488
-22.5%
203,6840.0%0.43%
-13.7%
Q2 2023$8,306,234
+9.4%
203,6840.0%0.50%
-9.8%
Q1 2023$7,591,303
+6.8%
203,6840.0%0.55%
+24.4%
Q4 2022$7,106,535
-37.7%
203,6840.0%0.44%
-49.7%
Q3 2022$11,398,000
+8.1%
203,6840.0%0.88%
-11.8%
Q2 2022$10,543,000
-28.8%
203,6840.0%1.00%
-21.1%
Q1 2022$14,802,000203,6841.26%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders